Back

Clinical outcomes of management options for significant unprotected left main coronary artery disease

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Outcomes in left main percutaneous coronary intervention Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Guang Ming Tan

The Chinese University of Hong Kong, Shatin (Hong Kong)

8 More presentations in this session

Presentation thumbnail
Cardiovascular events following directional coronary atherectomy: a comparison of drug-coated balloon vs. newer-generation drug-eluting stent in left main coronary artery bifurcation lesions
Doctor K. Murai (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Ostial stent coverage in LMCA PCI: impact on long-term outcomes
Assistant Professor Y. Takei (Yokohama, JP)
Abstract Slides Video
Presentation thumbnail
Stent expansion in novel platinum-chromium versus conventional cobalt-chromium everolimus-eluting stents for left main coronary artery disease: the MAGARS-LM study
Doctor T. Warisawa (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Five-year outcome after unprotected distal left main percutaneous coronary interventions according to complexity defined by DEFINITION criteria
Doctor O. Nemeth (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Long-term impact of diabetes on mortality in patients undergoing unprotected left main PCI: a propensity score-matched analysis
Mr E. Dabrowski (Bialystok, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Outcomes in left main percutaneous coronary intervention

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Myocardial revascularisation spotlight: what’s new in CABG vs. PCI
thumbnail
Congress Presentation
Five-year outcome after unprotected distal left main percutaneous coronary interventions according to complexity defined by DEFINITION criteria
thumbnail
Congress Session
Decision-making for revascularisation of multivessel disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources